Micronized Progesterone for Premenstrual Syndrome (PMS)
Micronized progesterone is not effective for treating premenstrual syndrome symptoms and should not be recommended as a treatment option for PMS. Multiple controlled studies have demonstrated that progesterone therapy, including micronized progesterone, is ineffective for PMS symptom relief 1, 2, 3.
Evidence Against Progesterone for PMS
A double-blind, placebo-controlled trial of oral micronized progesterone (300 mg daily) versus vaginal progesterone (200 mg daily) found no difference between active treatments and placebo for PMS symptoms 4.
A definitive randomized, placebo-controlled study of 168 women using progesterone suppositories (400 mg and 800 mg doses) showed no significant improvement in PMS symptoms compared to placebo across all measured outcomes 2.
A rigorous double-blind trial comparing oral micronized progesterone (1760 mg mean daily dose), alprazolam, and placebo found that oral micronized progesterone was no better than placebo for PMS treatment 3.
More Effective Alternatives for PMS
For patients seeking treatment for PMS symptoms, consider these evidence-based alternatives:
Non-hormonal options:
- SSRIs (particularly paroxetine, fluoxetine) - shown to be particularly effective for depressive symptoms in PMS 1
- Venlafaxine
- Cognitive behavioral therapy
- Relaxation techniques
Hormonal alternatives:
Important Clinical Considerations
- The misconception that progesterone is effective for PMS persists despite substantial evidence to the contrary.
- Some studies suggest progesterone might actually worsen certain PMS symptoms 1.
- While micronized progesterone has legitimate uses in other conditions (such as hormone replacement therapy in menopause 5 or for short cervix in pregnancy 6), it should not be prescribed for PMS.
- When considering hormonal therapy for PMS, estrogen-containing options are more likely to provide symptom relief than progesterone alone.
Contraindications and Cautions
If considering other hormonal therapies for PMS:
- Avoid micronized progesterone in patients with severe peanut allergies, as many formulations contain peanut oil in the excipients 6
- Contraindications for hormonal therapy include active liver disease, history of breast cancer (particularly hormone receptor-positive), history of coronary heart disease, previous venous thromboembolism or stroke 5
In conclusion, despite its widespread use, micronized progesterone should not be recommended for PMS treatment as multiple high-quality studies have consistently demonstrated its ineffectiveness for this indication.